monkey monoclonal antibody

In demand of humanization or other relevant applications, even higher affinity monkey (NHP) monoclonal antibodies can be achieved from Creative Biolabs. The Creative Biolabs research team have developed the Native™ Antibody Discovery Platform combined with the antigen-specific B lymphocytes cytometry technology. This platform can isolate large amount of candidate antibodies with in vivo native paired heavy- and light-chains. Due to the native characteristics, these monkey (NHP) antibodies are predicted to have higher specificity and affinity than produced by other technologies. Furthermore, our native monkey (NHP) antibody is considered more promising in subsequent drug development, as well as in humanization of monkey antibody.